CCRN vs. MD, AMN, LH, DGX, DVA, CHE, CRVL, AMED, BBSI, and KFRC
Should you be buying Cross Country Healthcare stock or one of its competitors? The main competitors of Cross Country Healthcare include Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), CorVel (CRVL), Amedisys (AMED), Barrett Business Services (BBSI), and Kforce (KFRC).
Cross Country Healthcare vs.
Pediatrix Medical Group (NYSE:MD) and Cross Country Healthcare (NASDAQ:CCRN) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, risk, community ranking, analyst recommendations, dividends, media sentiment, institutional ownership and profitability.
Cross Country Healthcare has higher revenue and earnings than Pediatrix Medical Group. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Pediatrix Medical Group, indicating that it is currently the more affordable of the two stocks.
Cross Country Healthcare has a net margin of -0.12% compared to Pediatrix Medical Group's net margin of -12.65%. Pediatrix Medical Group's return on equity of 12.79% beat Cross Country Healthcare's return on equity.
Pediatrix Medical Group has a beta of 1.58, indicating that its share price is 58% more volatile than the S&P 500. Comparatively, Cross Country Healthcare has a beta of 0.46, indicating that its share price is 54% less volatile than the S&P 500.
In the previous week, Cross Country Healthcare had 1 more articles in the media than Pediatrix Medical Group. MarketBeat recorded 5 mentions for Cross Country Healthcare and 4 mentions for Pediatrix Medical Group. Cross Country Healthcare's average media sentiment score of 0.87 beat Pediatrix Medical Group's score of 0.69 indicating that Cross Country Healthcare is being referred to more favorably in the news media.
Pediatrix Medical Group currently has a consensus target price of $16.25, suggesting a potential upside of 17.40%. Cross Country Healthcare has a consensus target price of $18.54, suggesting a potential upside of 1.96%. Given Pediatrix Medical Group's stronger consensus rating and higher probable upside, equities analysts clearly believe Pediatrix Medical Group is more favorable than Cross Country Healthcare.
Pediatrix Medical Group received 35 more outperform votes than Cross Country Healthcare when rated by MarketBeat users. However, 64.26% of users gave Cross Country Healthcare an outperform vote while only 60.31% of users gave Pediatrix Medical Group an outperform vote.
97.7% of Pediatrix Medical Group shares are held by institutional investors. Comparatively, 96.0% of Cross Country Healthcare shares are held by institutional investors. 1.2% of Pediatrix Medical Group shares are held by company insiders. Comparatively, 4.9% of Cross Country Healthcare shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Summary
Pediatrix Medical Group beats Cross Country Healthcare on 10 of the 18 factors compared between the two stocks.
Get Cross Country Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for CCRN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cross Country Healthcare Competitors List
Related Companies and Tools
This page (NASDAQ:CCRN) was last updated on 1/21/2025 by MarketBeat.com Staff
